>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Newsroom

News of the Hour News Reader Market News Stock News Topics Social Sentiments Market TV Press Releases
Articles > Top gainers in Biotechnology and Gene Therapy - CLLS, LLY, TMO, WAT, IDXX

Top gainers in Biotechnology and Gene Therapy - CLLS, LLY, TMO, WAT, IDXX

By KlickAnalytics Data Insights  |   April 3, 2024 04:40PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.

Cellectis (CLLS)
CLLS is trading UP for the last 1 days, and it at trading at $2.78 with volume of 42,570 and a one day change of $0.16 (6.23%). Cellectis has a 52-week low of 0.96 and a 52-week high of $3.77. The business's 50-day moving average price is $2.63 and its 200 day moving average price is $2.49. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 3.14.

For more information on CLLS:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Lilly(Eli) & Co (LLY)
    LLY is trading UP for the last 2 days, and it at trading at $776.03 with volume of 2,380,641 and a one day change of $12.07 (1.58%). Lilly(Eli) & Co has a 52-week low of 342.30 and a 52-week high of $800.78. The business's 50-day moving average price is $765.36 and its 200 day moving average price is $640.86. The firm has a market cap of $726 million, a P/E ratio of 131.49, and a beta of 0.34.

    Top news headlines for LLY

  • The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy's stability is reflected in the decreasing odds for a June rate cut, indicating optimism about future monetary policy.
  • Zepound—an Eli Lilly-produced drug that has become a popular alternative to other weight loss drugs such as Wegovy and Ozempic—is facing a shortage in the U.S. of some of its doses because of the growing demand for the drug, according to a warning from the Food and Drug Administration issued Wednesday.
  • Drugmakers spent big on ads for weight loss and diabetes drugs such as Wegovy and Ozempic. Meanwhile, the FDA approved the first AI diagnostic tool for sepsis.

    • For more information on LLY:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Thermo Fisher Scientific Inc. (TMO)
    TMO is trading UP for the last 1 days, and it at trading at $576.53 with volume of 813,790 and a one day change of $4.97 (0.87%). Thermo Fisher Scientific Inc. has a 52-week low of 415.60 and a 52-week high of $603.78. The business's 50-day moving average price is $573.75 and its 200 day moving average price is $521.41. The firm has a market cap of $220 million, a P/E ratio of 37.30, and a beta of 0.80.

    Top news headlines for TMO

  • The Investment Committee gives you their top stocks to watch for the second half.

    • For more information on TMO:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Waters Corp. (WAT)
    WAT is trading UP for the last 1 days, and it at trading at $341.28 with volume of 172,948 and a one day change of $1.55 (0.46%). Waters Corp. has a 52-week low of 231.90 and a 52-week high of $363.79. The business's 50-day moving average price is $340.14 and its 200 day moving average price is $300.26. The firm has a market cap of $20 million, a P/E ratio of 38.99, and a beta of 0.93.

    For more information on WAT:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • Idexx Laboratories, Inc. (IDXX)
    IDXX is trading UP for the last 2 days, and it at trading at $523.93 with volume of 228,881 and a one day change of $2.26 (0.43%). Idexx Laboratories, Inc. has a 52-week low of 372.50 and a 52-week high of $583.39. The business's 50-day moving average price is $551.11 and its 200 day moving average price is $502.43. The firm has a market cap of $44 million, a P/E ratio of 53.03, and a beta of 1.27.

    For more information on IDXX:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

    • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

    Market News ×
    Loading news…